Menu ×


Large Volume Wearable Injectors Market Analysis by Product Type (On-Body, Off-Body, and Handheld); by Device Type (Infusion Pumps, and Patch Pumps); by Usability (Disposable, and Reusable); and by Therapeutic Area (Cardiovascular Disorders, Infectious Diseases, Neurological Disorders, Oncological Disorders, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • Becton, Dickinson and Company has collaborated with Labcorp, a leading global life sciences company. This collaboration is expected to create a framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) with life-changing treatments for cancer and other diseases.
  • Insulet Corporation announces fully market releases of Omnipod 5 Automated Insulin Delivery (AID) System through U.S. retail pharmacy channels for individuals aged six years and older with type 1 diabetes.

Global Large Volume Wearable Injectors Market Size, Forecast, and Trend Highlights Over 2023 - 2033

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 2.3 Billion

Forecast Year Market Size (2033)

~ USD 9.9 Billion

The global large volume wearable injectors market is estimated to garner a revenue of ~USD 9.9 billion by the end of 2033 by growing at a CAGR of ~14% over the forecast period, i.e., 2023 – 2033. Further, the market generated revenue of ~USD 2.3 billion in the year 2022. The primary growth factor for the market is projected to be the rising cases of chronic diseases around the globe and deaths owing it. As per a recent study in 2020, it was estimated that around 40 million people are killed globally by chronic diseases. Further, it was estimated by the Centers for Disease Control and Prevention that 6 out of 10 adults in the United States are living with one chronic disease, whereas 4 out of 10 adults have been diagnosed with more than two chronic diseases in the year 2022.


Get more information on this report: Request Sample PDF

Large volume wearable injectors are drug delivery devices used for single-step administration of drugs for lengthier extent. These devices are designed to stick to the patient’s body. A large reservoir is used for storing and delivering sufficient amount of medications via subcutaneous tissues more quickly and safely. The increasing prevalence of non-communicable diseases among the global population and the growth in deaths due to it, is anticipated to bolster the demand of large volume wearable injectors. According to a recent World Health Organization (WHO) study published in 2021, non-communicable diseases (NCDs) kill approximately 41 million people worldwide each year. This is equivalent to around 71% of the total global deaths.

Global Large Volume Wearable Injectors Market: Growth Drivers and Challenges

Growth Drivers

  • Increase in Deaths by Cardiovascular Diseases Around the World – As per the statistics shared by the World Health Organization (WHO) in 2021, around 17.9 million people globally died due to cardiovascular diseases in 2019. It was approximately 32% of all the global deaths.  
  • Rising Autoimmune Diseases – The report released by the National Institute of Environmental Health Sciences revealed that more than 24 million people are affected by autoimmune illnesses.
  • High Expenditure in Healthcare – As per the World Bank, the global health expenditure accounted to 9.83% of the total GDP in 2019. This is a significant rise from 9.37% of the total GDP in 2013.
  • Burgeoning Geriatric Population – The United States stated that there were 703 million people who aged 65 years and above across the whole world in 2019. Further, this number is projected to rise significantly to 1.5 billion by 2050.  
  • Boom in Healthcare Sector – As per recent estimates, the revenue generated by India’s healthcare sector was approximately USD 300 billion in 2020, which is further anticipated to rise to USD 380 billion by 2022.


  • Rising Concerns About Lack of Reimbursement
  • Extra Expenses with the Equipment
  • Lack of Proper Knowledge

The large volume wearable injectors market is segmented and analyzed for demand and supply by product type into on-body, off-body, and handheld wearable injectors. Out of these segments, the on-body segment captured the largest market share by 52% in the year 2022, backed by the rising adoption of technologically advanced products along with rising development in wearable technology. Furthermore, the market is segmented by therapeutic areas into cardiovascular disorders, infectious diseases, neurological disorders, oncological disorders, and others. Out of these, cardiovascular disorders segment is anticipated to garner the modest revenue by 2033, owing to the rising global burden due to prevalence of cardiovascular disorders. As per recent statistics done in 2022, it is revealed that in the United States, every 34 seconds, one adult dies due to cardiovascular disease. Also, 697,000 people in the United States died from heart disease in 2020, accounting to be 1 in every 5 deaths.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Large Volume Wearable Injectors Market Regional Synopsis

Regionally, the global large volume wearable injectors market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these, the market in North America held the largest market share by ~52% in the year 2022, owing to rising chronic cases in the region. Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. They are also the leading drivers of the nation’s USD 4.1 trillion in annual health care costs. Further, the boom in healthcare industry is an another growth factor for the large volume wearable injectors market growth. The revenue generated by the U.S. healthcare industry stood at USD 800 billion as of 2021.


The global large volume wearable injectors market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global large volume wearable injectors market includes the following segments:

By Product Type

  • On-Body (52%)
  • Off-Body (9.9%)
  • Handheld (18%)

By Device Type

  • Infusion Pumps
  • Patch Pumps

By Usability

  • Disposable
  • Reusable

By Therapeutic Areas

  • Cardiovascular Disorders
  • Infectious Diseases
  • Neurological Disorders
  • Oncological Disorders
  • Others

Top Featured Companies Dominating the Global Large Volume Wearable Injectors Market

  • Insulet Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Becton, Dickinson and Company
  • Ypsomed AG
  • Amgen Inc.
  • United Therapeutics Corporation
  • West Pharmaceutical Services, Inc.
  • Frederick Furness Publishing
  • Crunchbase, Inc.
  • Frederick Furness Publishing
  • Eitan Medical Ltd.



Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved